Metabolites of thyrotropin releasing hormone inhibit angiotensin converting enzyme in vitro.
D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D004151:Dipeptides / Q000494:pharmacology; D007700:Kinetics; D008168:Lung / Q000201:enzymology; D010456:Peptides, Cyclic / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D011817:Rabbits; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000494:pharmacology
D000806:Angiotensin-Converting Enzyme Inhibitors; D004151:Dipeptides; D010456:Peptides, Cyclic; D010879:Piperazines; C035699:histidylproline; C014109:thyrotropin-releasing hormone, 3-Me-; D013973:Thyrotropin-Releasing Hormone; C015924:histidyl-proline diketopiperazine; D011761:Pyrrolidonecarboxylic Acid